Message from the Dean

Icahn School of Medicine at Mount Sinai is proud to be a national and international leader in biomedical education, research and patient care. Since its inception 50 years ago, Mount Sinai's renowned faculty, talented students and dedicated staff have risen to the challenges of our visionary founders to build an outstanding medical school.

A culture of innovation, a passion for pushing the boundaries of knowledge, and a deep respect for the diversity of backgrounds and ideas of all who come here to work, learn or seek help, are integral to the activities at Icahn School of Medicine at Mount Sinai. On a daily basis, we challenge existing limitations of science and medicine to create and discover what was previously thought to be impossible.  

"It is my goal to have Mount Sinai graduates remake the image of American physicians and scientists — committed, selfless, and ethical, and at the same time, translational and transformative." Dean Dennis S. Charney, MD

Ranked 13th among all medical schools in the United States in funding from the National Institutes of Health (NIH), Icahn School of Medicine at Mount Sinai was awarded over $318M for research in Federal Fiscal Year 2016-2017. Grant dollars per Mount Sinai investigator are among the highest in the nation. Four Mount Sinai basic science departments – Neuroscience, Pharmacological Sciences, Microbiology, and Genetics and Genomic Sciences – rank among the top five nationwide in NIH funding in their disciplines.

A $2.25 billion, 10-year Strategic Plan at Icahn School of Medicine at Mount Sinai was recently completed and enormously successful. Emphasizing translational medicine -- the continuum of discovery from laboratory research to the delivery of patient care -- it supported a broad range of important initiatives, including: establishment of 19 multidisciplinary research institutes to spur collaboration and discovery; construction of the Leon and Norma Hess Center for Science and Medicine, which places scientists and physicians in close proximity to maximize cross-pollination of ideas; heavy investment in the Tisch Cancer Institute, resulting in a coveted National Cancer Institute designation; creation of the largest high-performance computing cluster in all of Academic Medicine; launching of Sema4, a next-generation genomic testing company merging big data analytics and diagnostic testing to improve diagnosis, treatment and disease prevention; a significant increase in Mount Sinai patents and start-ups; and patient-centered discoveries in many disease areas, including but not limited to the clinical neurosciences, cancer, endocrinology, cardiac care, gastroenterology and infectious diseases.

An exciting new Strategic Plan for Icahn School of Medicine at Mount Sinai provides a roadmap for the next five years.  Combining the research, clinical and educational expertise of our faculty with the large and diverse patient population of the Mount Sinai Health System, the new Strategic Plan will support discovery and growth in many areas through:

  • Establishment of additional multidisciplinary research institutes in addiction, women’s health, exposomics, adolescent health and clinical trials;
  • Heavy investment in Precision Medicine and Precision Immunology. Precision Medicine initiatives will tie therapeutics to each patient’s unique genetic profile, focusing initially on diabetes and obesity, infectious diseases, heart disease, gastroenterology, renal care, pulmonary care and pediatrics. Precision Immunology research will pursue revolutionary drug development aimed at immune system modulation to treat cancer, immunodeficiency and inflammatory diseases, mucosal and skin immunity, allergies and transplantation, and expand the reach of immunology to a diverse range of other conditions.
  • Investment in surgical and rehabilitation innovations featuring sophisticated simulation capabilities and cutting-edge therapeutics;
  • Introduction of medical education innovations to enhance individual learning and embrace the diversity of our students and our patients;
  • Implementation of creative curricular reform in our PhD and Master’s programs to position students and trainees for innovation and discovery;
  • Establishment of new Centers of Excellence in areas with special potential, e.g., Neurotherapeutics, Discovery Medicine, Immuno-Therapeutics and Genome Editing.

As the sole medical school partnering with the eight member hospitals of the Mount Sinai Health System -- including The Mount Sinai Hospital, ranked among the nation's best -- Icahn School of Medicine at Mount Sinai serves and studies a large and diverse patient population. Emphasizing a a patient-centered model of clinical care, our multidisciplinary Mount Sinai Doctors Faculty Practice is growing rapidly and receives excellent patient feedback. An expanding primary care presence complements our renowned tertiary and quaternary services, creating a continuum of care that ensures the highest quality services for all of our patients. Basic research and translational medicine discoveries throughout the Health System support cutting-edge approaches to the diagnosis, prevention and treatment of disease.

This dynamic environment of research and clinical excellence provides a remarkable setting for learning at Icahn School of Medicine at Mount Sinai. Under the tutelage of Mount Sinai’s acclaimed faculty, our highly qualified and diverse student body pursues MD, PhD and Master’s degrees, and clinical and research fellows undertake postdoctoral training. All are carefully trained to become experts in medicine, science and related fields, while at the same time developing as informed advocates and catalysts for progress. Indeed, student commitment to service is quite high, reflected in activities such as the East Harlem Health Outreach Partnership (EHHOP); operated by our medical students, EHHOP provides confidential, no cost, high quality primary care to uninsured area residents. In times of crisis, our students are early responders, as compellingly demonstrated through hurricane relief efforts and other emergencies. The Mount Sinai Human Rights Program advances health, dignity, and justice by providing pro-bono, trauma-informed medical assessments, mental health evaluations, and access to social services and continuity medical care to U.S. asylum seekers who are survivors of torture and human rights abuses. The Arnhold Institute for Global Health, among others, provides additional venues for students and their mentors to improve the health of people around the world through research, education and patient care initiatives.

Icahn School of Medicine at Mount Sinai educators take pride in developing cutting-edge approaches that optimize student experiences and serve as models for other schools. Progressive curricula blend the teaching of essential factual material with real-life applications and experiences; combined with an emphasis on collaboration and lifelong learning, Mount Sinai students are well-prepared for successful careers in their chosen fields.

Affiliations with other institutions foster student and faculty interactions well beyond the boundaries of our campus. Medical students and house staff train at member hospitals of the Mount Sinai Health System, at the City Hospital Center at Elmhurst, and at the Bronx Veterans’ Administration Medical Center. Relationships with Rensselaer Polytechnic Institute, State University of New York at Stony Brook, the City University of New York, and the Pasteur Institute in Paris pair the unique biomedical research and patient care strengths of Mount Sinai with the engineering, computational, prototyping and other expertise of our partners. We aim to use these complementary research and educational programs to develop new medical care and treatment approaches in such diverse areas as neuroscience and neurological diseases, genomics, imaging, orthopedics, cancer, cardiovascular disease and virology. Through an affiliation with National Jewish Health in Denver, the nation's leading respiratory hospital, we are working towards research and clinical care breakthroughs in respiratory and related diseases.

I welcome you to learn more about Icahn School of Medicine. Explore our website, meet our faculty and talk to our students. The expertise, accomplishments, creativity, enthusiasm and commitment you encounter are certain to persuade you that Icahn School of Medicine at Mount Sinai is the place you want to be.

Dennis S. Charney, MD
Anne and Joel Ehrenkranz Dean
Icahn School of Medicine at Mount Sinai
President for Academic Affairs
Mount Sinai Health System